Mithra Pharmaceuticals S A : Half Year 2020 Results

Interim Financial Report

as at 30 June 2020

This report is prepared in accordance with article 13 of the Royal Decree of 14 November 2007.

Mithra Pharmaceuticals SA (hereinafter "Mithra" or the "Company") has prepared its interim financial report in

French and in English. In case of discrepancies between both versions, the French version shall prevail.

Mithra Pharmaceuticals SA/NV,

A limited liability company (société anonyme / naamloze vennootschap) incorporated under Belgian law, with its registered office at rue Saint-Georges 5, 4000 Liège (enterprise number 0466.526.646)

2

Table of contents
I. Interim management report..............................................................................................................................................	5
1.	Corporate presentation.................................................................................................................................................	5
2.	Operational Highlights including post-period end ...................................................................................................	5
3.	Financial highlights .......................................................................................................................................................	6
	3.1. Income statement..................................................................................................................................................	6
4. Corporate Governance..................................................................................................................................................	8
	4.1. Capital and shares .................................................................................................................................................	8
	4.2. Shareholders & Shareholder structure ...............................................................................................................	8
	4.3. Change and/or renewal in the composition of corporate bodies .................................................................	9
5.	Principal risks and uncertainties...............................................................................................................................	10
6.	Related party transactions.........................................................................................................................................	10
II. Interim condensed consolidated financial statements for the six months ended 30 June 2020 ...................	12
1.	Interim consolidated statement of income statement (unaudited) ..................................................................	12
2. Interim consolidated statement of other comprehensive income (unaudited)...............................................	13
3.	Interim consolidated statement of financial position (unaudited).....................................................................	14
4.	Interim consolidated statement of changes in equity (unaudited)....................................................................	16
5.	Interim Consolidated Cash Flow statement (unaudited).....................................................................................	17
6.	Notes to interim condensed consolidated financial statements .......................................................................	18
	6.1. Significant changes in the current reporting period ......................................................................................	18
	6.2. Summary of significant accounting policies ..................................................................................................	19
	6.3. Segment information...........................................................................................................................................	21
	6.4. Result for the period ............................................................................................................................................	22
	6.5. Income tax .............................................................................................................................................................	22
	6.6. Earnings per share ...............................................................................................................................................	23
	6.7. Intangible assets and goodwill ..........................................................................................................................	23
	6.8. Property, plant and equipment and right of use assets................................................................................	24
	6.9. Trade and other receivables...............................................................................................................................	24
	6.10. Share capital .......................................................................................................................................................	24
	6.11. Financial Liabilities.............................................................................................................................................	26
	6.12. Financial instruments .......................................................................................................................................	26
	6.13. Share-based payments .....................................................................................................................................	30
	6.14. Revenue and other operating income............................................................................................................	31
	6.15. Leases ..................................................................................................................................................................	34
	6.16. Commitments.....................................................................................................................................................	34
	6.17. Events after reporting period ...........................................................................................................................	35
	6.18. Financial Risk Management ............................................................................................................................	35
	6.19. Alternative performance measures................................................................................................................	36
III. Statement of the responsible persons .......................................................................................................................	38
IV. Statutory auditor's report..............................................................................................................................................	40

3

I.

Interim management report

4